IL18 and atherosclerosis: In the group of the subclinical inflammatory markers of atherosclerosis assessed in this study, significant drops in both groups concerned PTX3 (study group 1: from 1336.33 ± 395.15 to 1121.75 ± 351.17 [pg/mL], p = 0.013; study group 2: from 1610.76 ± 537.78 to 1376.92 ± 529.19 [pg/mL], p = 0.017) (Figure 3), and IL-18 (study group 1: from 11.89 (9.72–13.98) to 9.15 (8.62–10.06) [pg/mL], p = 0.005; study group 2: from 11.58 (10.87–16.97) to 9.65 (8.43–10.95) [pg/mL], p = 0.003) (Figure 4).